Tech Company Financing Transactions
Bexorg Funding Round
Bexorg secured a $28.3 million funding round on 10/7/2026. Investors included Advanced Research Projects Agency for Health (ARPA-H).
Transaction Overview
Company Name
Announced On
10/7/2026
Transaction Type
Debt
Amount
$28,300,000
Round
Undisclosed
Proceeds Purpose
The funding will support a three-phase, 36-month project which aims to extend BrainEx perfusion from 24 hours up to two weeks, creating a longer window for longitudinal studies of human brain pharmacology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
290 Congress Avenue
New Haven, CT 06519
USA
New Haven, CT 06519
USA
Phone
Undisclosed
Website
Email Address
Overview
Spun out of Yale University, Bexorg is revolutionizing how CNS medicines are discovered and developed. We created a platform that leverages the untouched potential of nature's most complex and enduring mystery: the human brain. Limitations are merely challenges yet to be tackled, and what seems impossible to achieve is really right around the corner. Be bold and courageous, and you'll fit right in. We not only take our science seriously, but also each other. Everyone - from our diverse team to our generous donors - is treated with respect and gratitude.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 10/7/2026: Furientis venture capital transaction
Next: 10/7/2026: Omni Bridgeway venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








